Triad Wealth Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Triad Wealth Partners's AMGN Position: Q3 2026 in Review
Triad Wealth Partners reduced its Amgen (AMGN) stake by 2.7% in Q3 2026, selling an estimated $23.1K and leaving 2,111 shares worth $890K. The position accounts for 0.05% of the portfolio, ranked #226.
Triad Wealth Partners first reported a position in AMGN in Q2 2024 and has held it in 7 quarters since. 2,617 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Triad Wealth Partners held 2,111 shares of Amgen worth $890K as of Q3 2026.
- Triad Wealth Partners sold 58 Amgen shares in Q3 2026, an estimated $23.1K.
- Amgen made up 0.05% of Triad Wealth Partners's portfolio in Q3 2026, its #226 holding.
- Triad Wealth Partners first reported a position in Amgen in Q2 2024 and has held it in 7 quarters since.
- 2,617 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Triad Wealth Partners's 13F filing for Q3 2026, filed 26 Oct 2026.